patient<===>gender<===>country<===>popDensity<===>drugName<===>indication<===>formula<===>compound<===>ChemicalEquation<===>ReactionTitle
http://tcga.deri.ie/TCGA-60-2708<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2708<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2609<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2609<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2707<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2707<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-4595<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-4595<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-8391<===>"FEMALE"<===>http://dbpedia.org/resource/Germany<===>"228.959"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-8391<===>"FEMALE"<===>http://dbpedia.org/resource/Germany<===>"229.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2704<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2704<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5489<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5489<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-33-6738<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-33-6738<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-6837<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-6837<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-96-A4JK<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-96-A4JK<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-L3-A524<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-L3-A524<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Gemcitabine"<===>"For the first-line treatment of patients with metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and as first-line treatment for patients with adenocarcinoma of the pancreas."<===>"C9H11F2N3O4"<===>http://bio2rdf.org/cpd:C07650<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-85-6561<===>"MALE"<===>http://dbpedia.org/resource/Russia<===>"8.3"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-85-6561<===>"MALE"<===>http://dbpedia.org/resource/Russia<===>"8.3012"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-6837<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-6837<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-A4EE<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-A4EE<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-92-7340<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-92-7340<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-92-8064<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-92-8064<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-96-A4JK<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-96-A4JK<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-L3-A524<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-L3-A524<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-MF-A522<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-MF-A522<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-NC-A5HE<===>"MALE"<===>http://dbpedia.org/resource/Switzerland<===>"184.325"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-NC-A5HE<===>"MALE"<===>http://dbpedia.org/resource/Switzerland<===>"188.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-NC-A5HG<===>"MALE"<===>http://dbpedia.org/resource/Switzerland<===>"184.325"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-NC-A5HG<===>"MALE"<===>http://dbpedia.org/resource/Switzerland<===>"188.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-33-4587<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Vincristine"<===>"For treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, acute panmyelosis"<===>"C46H56N4O10"<===>http://bio2rdf.org/cpd:C07204<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-33-4587<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Vincristine"<===>"For treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, acute panmyelosis"<===>"C46H56N4O10"<===>http://bio2rdf.org/cpd:C07204<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5472<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5472<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5021<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5021<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-85-6561<===>"MALE"<===>http://dbpedia.org/resource/Russia<===>"8.3"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-85-6561<===>"MALE"<===>http://dbpedia.org/resource/Russia<===>"8.3012"^^<http://www.w3.org/2001/XMLSchema#double><===>"Etoposide"<===>"For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme."<===>"C29H32O13"<===>http://bio2rdf.org/cpd:C01576<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-2576<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-2576<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-2581<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-2581<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2605<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2605<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2724<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2724<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2710<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-60-2710<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5483<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5483<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-5240<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-5240<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5037<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5037<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8118<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8118<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-A475<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-A475<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-51-4081<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-51-4081<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-8387<===>"MALE"<===>http://dbpedia.org/resource/Germany<===>"228.959"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-8387<===>"MALE"<===>http://dbpedia.org/resource/Germany<===>"229.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Cisplatin"<===>"For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer."<===>"Cl2H6N2Pt"<===>http://bio2rdf.org/cpd:C06911<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8115<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8115<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Paclitaxel"<===>"Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast."<===>"C47H51NO14"<===>http://bio2rdf.org/cpd:C07394<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2605<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-34-2605<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5472<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-22-5472<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5029<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-39-5040<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8118<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-43-8118<===>"FEMALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-A46L<===>"MALE"<===>http://dbpedia.org/resource/Germany<===>"228.959"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-58-A46L<===>"MALE"<===>http://dbpedia.org/resource/Germany<===>"229.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-A4EE<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'
http://tcga.deri.ie/TCGA-90-A4EE<===>"MALE"<===>http://dbpedia.org/resource/United_States<===>"32.0465"^^<http://www.w3.org/2001/XMLSchema#double><===>"Docetaxel"<===>"For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer."<===>"C43H53NO14"<===>http://bio2rdf.org/cpd:C11231<===>'null'<===>'null'